COMP <GO>
SOLV vs MRK // 10Y YIELD & FRED MACRO BETA
Solventum Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: SOLV 3
— MRK 12
▲ 10Y YIELD & FRED MACRO BETA LEADER: SOLV
LAST: $81.33 (-2.67%) • MKT CAP: $14.22B
macro-sensitivity
1.06
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SOLV VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SOLV | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.50% | 74.80% | -21.30 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.70% | 20.70% | -2.00 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.3x | 15.3x | -8.00 | SOLV | /valuation <GO> |
| Free Cash Flow Yield | -0.07% | 3.42% | -3.49 | MRK | /fcf-yield <GO> |
| Operating Margin | 26.20% | 34.30% | -8.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | 18.70% | 28.10% | -9.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 1.30% | -0.40 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.25 | 5.19 | -2.94 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.60% | +0.50 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.3 | 56.9 | -21.61 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.06 | 0.92 | +0.14 | SOLV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.5x | 18.4x | -9.90 | SOLV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.22B | $361.02B | -$346.80B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SOLV REV | MRK REV | SOLV GROSS % | MRK GROSS % | SOLV FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.32B | $65.01B | 53.5% | 74.8% | -$10.0M | $12.36B |
| FY 2024 | $8.25B | $64.17B | 55.6% | 76.3% | $805.0M | $18.10B |
| FY 2023 | $8.20B | $60.12B | 44.0% | 44.0% | $1.55B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SOLV // BETA 1.06
MRK // BETA 0.92